The impact of integrase inhibitors on steatosis and fibrosis biomarkers in persons with HIV naïve to antiretroviral therapy
Abstract Background Non-alcoholic Fatty Liver Disease (NAFLD) has a high prevalence among persons with HIV infection. Since Integrase Strand Transfer Inhibitors (INSTIs) are used worldwide and have been associated with weight gain, we must determine their effect in the development of NAFLD and Non-a...
Main Authors: | Sara Rodrigues Fernandes, Ana Rita Leite, Rita Lino, André Rodrigues Guimarães, Carmela Pineiro, Rosário Serrão, Paula Freitas |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-023-08530-3 |
Similar Items
-
Association between hypertension and the prevalence of liver steatosis and fibrosis
by: Huanjie Fu, et al.
Published: (2023-04-01) -
High prevalence of metabolic diseases, liver steatosis and fibrosis among Chinese psychiatric patients
by: Huixia Li, et al.
Published: (2023-03-01) -
Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis
by: Giovanna Cuomo, et al.
Published: (2023-05-01) -
Quantitative ultrasound envelope statistics imaging as a screening approach for pediatric hepatic steatosis and liver fibrosis: using biomarker and transient elastography as reference standards
by: Chiao-Shan Hsieh, et al.
Published: (2023-12-01) -
Fibrosis Predictive Score in Caucasian Patients with Metabolic Syndrome
by: Mare R, et al.
Published: (2022-06-01)